Answers are grounded in this paper and cite their sources.
Evaluates an AI-integrated biosensor for improved retinal disease detection, suggesting enhanced diagnostic accuracy.
Retinal diseases such as diabetic retinopathy, macular degeneration, and glaucoma are major causes of vision impairment worldwide, requiring early and accurate diagnosis. Conventional imaging methods, including fundus imaging and optical coherence tomography, mainly detect structural abnormalities and often fail to capture early-stage physiological changes. To address this limitation, this study proposes an AI-integrated diagnostic system using a piezoelectric nanoparticle biosensor platform for enhanced retinal disease monitoring. Sensitive piezoelectric nanomaterials, such as zinc oxide (ZnO) and barium titanate (BaTiO3), are incorporated into a nanoscale biosensing system to convert retinal biomechanical and cellular stimuli into electrical signals. The acquired data is collected through a microcontroller-based system and processed using preprocessing techniques including denoising, normalization, and feature extraction. A hybrid deep learning model combining convolutional neural networks (CNN) and recurrent neural networks (RNN) is developed to analyze the multidimensional biosensor data. The model achieves an accuracy of 96.4%, along with high precision, recall, and F1-score. Comparative analysis shows that the proposed system outperforms traditional diagnostic methods in sensitivity, specificity, and early detection capability. By integrating nanotechnology with artificial intelligence, the system enables detection of subtle physiological changes before structural damage occurs, offering a promising solution for real-time monitoring and improved clinical decision-making in ophthalmology.
No takes yet. Share an insight, caveat, or question.
S. et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: